ARVN Institutional Ownership
ARVINAS, INC.
Latest close $8.75 as of Aug 7, 2026
ARVN institutional ownership at a glance
Follow ARVINAS, INC. institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.
Latest filing: Citadel Advisors filed Schedule 13G amendment on Nov 14, 2025, reporting 264.2K shares and 0.40% beneficial ownership.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Institutional Research
This gauge summarizes recent agreement across tracked institutional activity.
1 accumulating, 1 reducing, 1 exited across 3 comparable institutions.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 9 filing(s) · 6 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Citadel Advisors CIK0001423053 | Sep 30, 2025 observed Nov 14, 2025 filed · 45d Schedule 13G amendment | Exit below reporting threshold | 264.2K -3.2M | 0.40% -4.70 pts | $8.52 | $10.57 | $8.75 |
| T. Rowe Price Associates CIK0000080255 | Jun 30, 2025 observed Aug 14, 2025 filed · 45d Schedule 13G amendment | Reported reduction | 1.3M -2.5M | 12.00% +6.40 pts | $7.36 | $7.08 | $8.75 |
| Citadel Advisors CIK0001423053 | Jan 23, 2025 observed Feb 14, 2025 filed · 22d Schedule 13G amendment | Reported shares unchanged | 3.5M 0 | 5.10% 0.00 pts | $18.00 | $18.31 | $8.75 |
Related research
Compare ARVN with other securities showing similar institutional activity or recent accumulation across several tracked institutions.